S&P revises Orlando Health’s outlook to positive

S&P Global Ratings revised Orlando Health’s outlook to positive from stable. The agency also affirmed the “A” long-term rating and underlying rating on the health system’s bonds.

Advertisement

The ratings affirmation is based on a variety of factors, including the health system’s consistently strong operating performance in recent years and improved balance sheet metrics.

“The outlook revision reflects our assessment of Orlando Health’s multiple years of very strong operations and cash flow, contributing to sustained coverage of maximum annual debt service exceeding 5x, coupled with improvement in key balance sheet metrics that generally reflect a higher rating,” said S&P analyst Margaret McNamara.

More articles on healthcare finance:
Decreased funding prompts closure of 4 Planned Parenthood clinics in Iowa
Gaffey Healthcare appoints CIO: 3 notes
Avadyne Health names Jayson Yardley CEO

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.